1. Home
  2. EOLS vs HBT Comparison

EOLS vs HBT Comparison

Compare EOLS & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • HBT
  • Stock Information
  • Founded
  • EOLS 2012
  • HBT 1920
  • Country
  • EOLS United States
  • HBT United States
  • Employees
  • EOLS N/A
  • HBT N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • HBT Major Banks
  • Sector
  • EOLS Health Care
  • HBT Finance
  • Exchange
  • EOLS Nasdaq
  • HBT Nasdaq
  • Market Cap
  • EOLS 854.0M
  • HBT 746.1M
  • IPO Year
  • EOLS 2018
  • HBT 2019
  • Fundamental
  • Price
  • EOLS $12.05
  • HBT $22.51
  • Analyst Decision
  • EOLS Strong Buy
  • HBT Hold
  • Analyst Count
  • EOLS 4
  • HBT 6
  • Target Price
  • EOLS $24.67
  • HBT $24.17
  • AVG Volume (30 Days)
  • EOLS 736.2K
  • HBT 32.6K
  • Earning Date
  • EOLS 03-04-2025
  • HBT 04-21-2025
  • Dividend Yield
  • EOLS N/A
  • HBT 3.67%
  • EPS Growth
  • EOLS N/A
  • HBT 9.18
  • EPS
  • EOLS N/A
  • HBT 2.26
  • Revenue
  • EOLS $266,274,000.00
  • HBT $221,390,000.00
  • Revenue This Year
  • EOLS $34.56
  • HBT $7.17
  • Revenue Next Year
  • EOLS $32.26
  • HBT $1.92
  • P/E Ratio
  • EOLS N/A
  • HBT $10.14
  • Revenue Growth
  • EOLS 31.76
  • HBT N/A
  • 52 Week Low
  • EOLS $9.25
  • HBT $18.00
  • 52 Week High
  • EOLS $17.82
  • HBT $26.25
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 35.35
  • HBT 39.10
  • Support Level
  • EOLS $13.07
  • HBT $22.61
  • Resistance Level
  • EOLS $13.66
  • HBT $23.28
  • Average True Range (ATR)
  • EOLS 0.58
  • HBT 0.50
  • MACD
  • EOLS -0.15
  • HBT -0.05
  • Stochastic Oscillator
  • EOLS 22.22
  • HBT 21.64

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About HBT HBT Financial Inc.

HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.

Share on Social Networks: